Investments
7Portfolio Exits
3Partners & Customers
10About Showa Denko
Showa Denko ("SDK"; TSE:4004, US:SHWDF) is a major manufacturer and marketer of chemical products serving a wide range of fields ranging from heavy industry to the electronic and computer industries. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial and high-performance gases and chemicals and high-purity gases and chemicals for the semiconductor industry, and the Inorganics Sector provides ceramics products such as alumina, abrasive, refractory and graphite electrodes and fine carbon products. Today, the Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high-bright LEDs and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components.

Want to inform investors similar to Showa Denko about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Showa Denko News
Feb 28, 2023
2023" - https://www.reportlinker.com/p06424027/?utm_source=GNW , Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc., Phenomenex, Jasco Inc., Hamilton Company, Tosoh Corporation, YMC CO Ltd., Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd., Sartorius AG and Mitsubishi Chemical Corporation. The global high-performance liquid chromatography market grew from $5.32 billion in 2022 to $5.79 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The high-performance liquid chromatography market is expected to grow to $7.36 billion in 2027 at a CAGR of 6.2%. The high-performance liquid chromatography market consists of revenues earned by entities by providing HPLC systems, pumps, detectors, and fraction collectors.The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The high-performance liquid chromatography refers to an analytical technique of separating, identifying, and quantifying components in a mixture.The process relies on pumps which are used to move a pressured liquid solvent containing the sample combination through a column containing a solid adsorbent material. This procedure allows for both quantitative and qualitative analysis. North America was the largest region in the high-performance liquid chromatography market in 2022.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-performance liquid chromatography market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The main product of high-performance liquid chromatography are instruments, consumables, and accessories.The instruments product of high-performance liquid chromatography is instrument used to perform holding packing material (stationary phase) and pumping mobile phase in high-performance liquid chromatography. Instruments in high-performance liquid chromatography refer to delivery systems, mobile phase/solvent reservoir, post-column apparatus, detector, data collection, output system, and others, that are applied in clinical research, diagnostics, forensic, and other applications, used by pharmaceutical and biotechnology industries, diagnostic laboratories, food and beverage industry, academic and research institutes and others end-users (environmental, forensic, chemicals and energy). The increasing prevalence of chronic diseases and acute diseases is expected to propel the demand for the high performance liquid chromatography market.Chronic diseases are long-lasting sicknesses that often cannot be healed. However, it is occasionally curable and controllable.The changing lifestyle, eating habits, and not maintaining body weight are the reason for chronic conditions; a few more prolonged chronic infections lead to cancerous risk. Growing exposure to these diseases raises the need for high performance liquid chromatography for a patient to treat complex chronic diseases.For instance, In September 2020, a research report published by American Action Forum identified that the prevalence and cost of chronic disease in the United States are growing and will continue to rise as the disease prevalence among young people and children rises. The increasing total cost of chronic disease in the United States reaches $3.7 trillion each year, approximately 19.6 percent of its gross domestic product, making it a severe issue in healthcare. Therefore increasing prevalence of chronic and acute diseases is driving the growth of the high performance liquid chromatography market. Technological advancement is the key trend that is gaining popularity in the high-performance liquid chromatography market.High-performance liquid chromatography (HPLC) has been frequently utilized for antibiotic analysis as it outperforms conventional microbiological techniques in terms of specificity, sensitivity, and analysis time. Recently, the market has witnessed ion exchange liquid chromatography techniques for detecting glycated hemoglobin (HbA1c) in blood samples.Ion exchange chromatography separates ions and polar compounds based on their affinity for ion exchangers. Major companies operating in high-performance liquid chromatography focus on research and development to develop technologically advanced tools and solutions to strengthen their market position.For instance, In June 2021, Trivitron Healthcare, an India-based company operating in the manufacturing and supply of medical devices, introduced NANO H5 and NANO H110 for the detection of glycated hemoglobin (HbA1c), measures the amount of glucose (sugar) in blood samples using ion exchange liquid chromatography. NANO H5 and NANO H110 are automated HPLC analyzer that offers dual test mode for the HbA1c test and Hb Variant detection. This new high-performance liquid chromatography analyzer detects HbA1c in less than three minutes. These HbA1c analyzers based on HPLC will be utilized to monitor diabetes, thalassemia, and hemoglobin variations. In January 2022, Bruker Corporation, a US-based manufacturer of scientific instruments for molecular and materials research, acquired Prolab Instruments GmbH for an undisclosed amount.Through this acquisition, Bruker Corporation aims to strengthen its product portfolio in proteomics and metabolomics workflows of high-performance mass spectrometry systems and to improve mobile injection unit technology. Prolab Instruments GmbH is a Switzerland-based company operating in high-performance liquid chromatography instruments. The countries covered in the high-performance liquid chromatography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The high-performance liquid chromatography market research report is one of a series of new reports that provides high-performance liquid chromatography market statistics, including high-performance liquid chromatography industry global market size, regional shares, competitors with a high-performance liquid chromatography market share, detailed high-performance liquid chromatography market segments, market trends and opportunities, and any further data you may need to thrive in the high-performance liquid chromatography industry. This high-performance liquid chromatography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Showa Denko Investments
7 Investments
Showa Denko has made 7 investments. Their latest investment was in AMI Automation as part of their Corporate Minority on February 2, 2021.

Showa Denko Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
2/5/2021 | Corporate Minority | AMI Automation | Yes | 1 | ||
8/9/2019 | Series A | |||||
12/25/2003 | Secondary Market - III | |||||
4/29/1998 | Secondary Market - II | |||||
12/31/1985 | Secondary Market |
Date | 2/5/2021 | 8/9/2019 | 12/25/2003 | 4/29/1998 | 12/31/1985 |
---|---|---|---|---|---|
Round | Corporate Minority | Series A | Secondary Market - III | Secondary Market - II | Secondary Market |
Company | AMI Automation | ||||
Amount | |||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 1 |
Showa Denko Portfolio Exits
3 Portfolio Exits
Showa Denko has 3 portfolio exits. Their latest portfolio exit was Showa Denko - Lead-Acid Battery Business on July 08, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
7/8/2021 | Divestiture | Showa Denko - Lead-Acid Battery Business | 1 | ||
Date | 7/8/2021 | ||
---|---|---|---|
Exit | Divestiture | ||
Companies | Showa Denko - Lead-Acid Battery Business | ||
Valuation | |||
Acquirer | |||
Sources | 1 |
Showa Denko Acquisitions
3 Acquisitions
Showa Denko acquired 3 companies. Their latest acquisition was Hitachi Chemical on November 26, 2019.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
11/26/2019 | Acq - Pending | 2 | ||||
5/29/2019 | ||||||
10/3/2017 |
Date | 11/26/2019 | 5/29/2019 | 10/3/2017 |
---|---|---|---|
Investment Stage | |||
Companies | |||
Valuation | |||
Total Funding | |||
Note | Acq - Pending | ||
Sources | 2 |
Showa Denko Partners & Customers
10 Partners and customers
Showa Denko has 10 strategic partners and customers. Showa Denko recently partnered with New Energy and Industrial Technology Development Organization on May 5, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
5/24/2022 | Partner | Japan | As a result , NEDO selected Showa Denko 's proposal for GI Fund Projects . | 1 | |
9/28/2021 | Client | Japan | Showa Denko agrees long-term SiC epi supply contract with Toshiba Tokyo-based wafer manufacturer Showa Denko K.K. has concluded a long-term supply contract with Japan 's Toshiba , which makes silicon carbide - based power semiconductor devices , to supply SiC epitaxial wafers for two and a half years . | 4 | |
9/13/2021 | Client | Japan | Showa Denko Concludes Long-Term Contract to Supply SiC Epitaxial Wafers for ROHM Co., Ltd. ROHM Co. , Ltd. decided to conclude this ling-term contract because the company appreciated high-quality and stable supply system of SDK 's SiC epi-wafers . | 1 | |
9/13/2021 | Client | ||||
9/9/2021 | Partner |
Date | 5/24/2022 | 9/28/2021 | 9/13/2021 | 9/13/2021 | 9/9/2021 |
---|---|---|---|---|---|
Type | Partner | Client | Client | Client | Partner |
Business Partner | |||||
Country | Japan | Japan | Japan | ||
News Snippet | As a result , NEDO selected Showa Denko 's proposal for GI Fund Projects . | Showa Denko agrees long-term SiC epi supply contract with Toshiba Tokyo-based wafer manufacturer Showa Denko K.K. has concluded a long-term supply contract with Japan 's Toshiba , which makes silicon carbide - based power semiconductor devices , to supply SiC epitaxial wafers for two and a half years . | Showa Denko Concludes Long-Term Contract to Supply SiC Epitaxial Wafers for ROHM Co., Ltd. ROHM Co. , Ltd. decided to conclude this ling-term contract because the company appreciated high-quality and stable supply system of SDK 's SiC epi-wafers . | ||
Sources | 1 | 4 | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.